| Glenmark Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532296 |
NSE Symbol : GLENMARK |
P/E(TTM) : 43.46 |
|
ISIN Demat : INE935A01035 |
Div & Yield% : 0.11 |
EPS(TTM) : 51.73 |
|
Book Value(₹) : 855.78 |
Market Cap(₹Cr) : 63,438.74 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 2,342.53 | 2,207.56 | 2,328.23 | 1,219.53 | 2,178.90 | 1,909.94 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,342.53 | 2,207.56 | 2,328.23 | 1,219.53 | 2,178.90 | 1,909.94 |
| Other Operating Income | 92.47 | -60.99 | 31.70 | 319.13 | 216.03 | 99.56 |
| Other Income | 338.41 | 307.88 | 109.06 | 285.76 | 69.34 | 88.45 |
| Total Income | 2,773.40 | 2,454.45 | 2,468.99 | 1,824.42 | 2,464.26 | 2,097.95 |
| Total Expenditure | 1,821.74 | 2,483.80 | 2,041.30 | 2,648.45 | 1,990.00 | 1,848.13 |
| PBIDT | 951.66 | -29.35 | 427.69 | -824.04 | 474.26 | 249.81 |
| Interest | 23.25 | 17.91 | 21.98 | 23.40 | 15.46 | 13.13 |
| PBDT | 928.42 | -47.26 | 405.71 | -847.43 | 458.80 | 236.68 |
| Depreciation | 62.32 | 60.13 | 59.18 | 58.93 | 57.64 | 55.53 |
| Tax | 112.84 | 0.00 | 0.00 | -70.17 | 70.17 | -25.62 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 17.62 | -33.50 | 64.46 | -97.01 | 0.77 | 59.02 |
| Reported Profit After Tax | 735.64 | -73.90 | 282.07 | -739.19 | 330.23 | 147.76 |
| Extra-ordinary Items | 189.41 | -368.76 | -144.13 | -931.79 | -266.07 | -120.80 |
| Adjusted Profit After Extra-ordinary item | 546.23 | 294.86 | 426.20 | 192.60 | 596.30 | 268.56 |
| EPS (Unit Curr.) | 26.07 | -2.62 | 10.00 | -26.19 | 11.70 | 5.24 |
| EPS (Adj) (Unit Curr.) | 26.07 | -2.62 | 10.00 | -26.19 | 11.70 | 5.24 |
| Calculated EPS (Unit Curr.) | 26.07 | -2.62 | 10.00 | -26.19 | 11.70 | 5.24 |
| Calculated EPS (Adj) (Unit Curr.) | 26.07 | -2.62 | 10.00 | -26.19 | 11.70 | 5.24 |
| Calculated EPS (Ann.) (Unit Curr.) | 104.27 | -10.48 | 39.98 | -104.78 | 46.81 | 20.94 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 104.27 | -10.48 | 39.98 | -104.78 | 46.81 | 20.94 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 40.63 | -1.33 | 18.37 | -67.57 | 21.77 | 13.08 |
| PBDTM(%) | 39.63 | -2.14 | 17.43 | -69.49 | 21.06 | 12.39 |
| PATM(%) | 31.40 | -3.35 | 12.12 | -60.61 | 15.16 | 7.74 |
